PKI 115.4 (+0.44%)
US7140461093Medical Diagnostics & ResearchDiagnostics & Research

PerkinElmer (PKI) Competitor Comparison

We are evaluating the key criteria listed to compare PerkinElmer (PKI) against its competitors in the Diagnostics & Research industry.

Performance 5 years - PKI ranking 16 / 58

These are the competitors of PerkinElmer in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
418.62
2. Natera NTRA
351.05
3. Medpace Holdings MEDP
276.44
4. RadNet RDNT
198.05
5. Twist Bioscience TWST
147.57
6. Meridian Bioscience VIVO
118.46
7. Thermo Fisher Scientific TMO
70.51
8. Danaher DHR
69.77
9. Waters WAT
69.48
10. Agilent Technologies A
69.3
11. DarioHealth DRIO
61.4
12. Mettler-Toledo MTD
59.21
13. Laboratory Corp of America Holdings LH
58.9
14. IDEXX Laboratories IDXX
51.05
15. DexCom DXCM
49.31
16. PerkinElmer PKI
48.44
17. Quest Diagnostics DGX
43.45
18. Qiagen QGEN
30.56
19. IQVIA Holdings IQV
26.43
20. Fulgent Genetics FLGT
24.35
21. Icon ICLR
14.14
22. Ortho Clinical Diagnostics Holdings OCDX
13.74
23. Heska HSKA
12.14
24. Co-Diagnostics CODX
6.45
25. Charles River Laboratories CRL
4.96
26. CareDx CDNA
3.19
27. Syneos Health SYNH
-16.98
28. Inotiv NOTV
-17.49
29. Olink Holding OLK
-26.82
30. Anixa Biosciences ANIX
-29.32
31. Bioventus BVS
-33.58
32. Exact Sciences EXAS
-39.43
33. Guardant Health GH
-42.74
34. Personalis PSNL
-47.33
35. Sotera Health SHC
-49.44
36. NeoGenomics NEO
-54.97
37. Myriad Genetics MYGN
-55.59
38. Sera Prognostics SERA
-56.36
39. Illumina ILMN
-57.27
40. Enzo Biochem ENZ
-65.26
41. Pacific Biosciences of California PACB
-65.86
42. Neogen NEOG
-67.35
43. MaxCyte MXCT
-72.57
44. National Research NRC
-74.4
45. Psychemedics PMD
-80.02
46. Exagen XGN
-80.91
47. Trinity Biotech TRIB
-81.02
48. MDxHealth MDXH
-83.54
49. Precipio PRPO
-84.23
50. Global Cord Blood CO
-86.47
51. Interpace Biosciences IDXG
-86.51
52. bioAffinity Technologies BIAF
-88.45
53. Neuronetics STIM
-92.42
54. Biodesix BDSX
-92.64
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.39

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.